John R. Moore

2017

In 2017, John R. Moore earned a total compensation of $1.4M as Vice President and General Counsel at Array BioPharma, a 58% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$150,909
Option Awards$663,281
Salary$386,005
Stock Awards$192,282
Other$32,748
Total$1,425,225

Moore received $663.3K in option awards, accounting for 47% of the total pay in 2017.

Moore also received $150.9K in non-equity incentive plan, $386K in salary, $192.3K in stock awards and $32.7K in other compensation.

Rankings

In 2017, John R. Moore's compensation ranked 7,250th out of 14,666 executives tracked by ExecPay. In other words, Moore earned more than 50.6% of executives.

ClassificationRankingPercentile
All
7,250
out of 14,666
51st
Division
Manufacturing
2,698
out of 5,772
53rd
Major group
Chemicals And Allied Products
881
out of 2,075
58th
Industry group
Drugs
689
out of 1,731
60th
Industry
Pharmaceutical Preparations
542
out of 1,333
59th
Source: SEC filing on September 13, 2017.

Moore's colleagues

We found five more compensation records of executives who worked with John R. Moore at Array BioPharma in 2017.

2017

Ron Squarer

Array BioPharma

Chief Executive Officer

2017

Andrew Robbins

Array BioPharma

Chief Operating Officer

2017

Victor Sandor

Array BioPharma

Chief Medical Officer

2017

Jason Haddock

Array BioPharma

Chief Financial Officer

2017

David Horin

Array BioPharma

Chief Financial Officer

You may also like